Clover Health Investments
CLOV
144 hedge funds and large institutions have $92.7M invested in Clover Health Investments in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 41 increasing their positions, 34 reducing their positions, and 23 closing their positions.
170% more call options, than puts
Call options by funds: $4.06M | Put options by funds: $1.5M
21% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 34
13% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 23
0.78% more ownership
Funds ownership: 23.57% → 24.35% (+0.78%)
1% more funds holding
Funds holding: 143 → 144 (+1)
8% less capital invested
Capital invested by funds: $101M → $92.7M (-$8.45M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$2.78M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.16M |
| 3 |
Renaissance Technologies
New York
|
+$2.14M |
| 4 |
Two Sigma Advisers
New York
|
+$1.77M |
| 5 |
Two Sigma Investments
New York
|
+$1.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.33M |
| 3 |
Millennium Management
New York
|
-$2.45M |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
-$1.41M |
| 5 |
State Street
Boston,
Massachusetts
|
-$363K |
CLOV Hedge Fund Activity: Q4 2023 in Review
144 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q4 2023, worth a combined $92.7M — down 8.4% from $101M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new CLOV positions and 23 closed out — a net gain of 3 holders — while 41 added to existing stakes and 34 trimmed.
The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $2.78M. The largest seller was Vanguard Group, cutting an estimated $6.3M.
- 144 institutional investors held Clover Health Investments (CLOV) as of Q4 2023, up from 143 in Q3 2023.
- Funds reported $92.7M of Clover Health Investments stock for Q4 2023, down 8.4% quarter-over-quarter.
- 26 funds opened new Clover Health Investments positions in Q4 2023 and 23 closed out, a net change of +3 holders.
- The largest Clover Health Investments buyer in Q4 2023 was D.E. Shaw & Co, an estimated $2.78M added.
- The largest Clover Health Investments seller in Q4 2023 was Vanguard Group, an estimated $6.3M sold.
Based on aggregated 13F filings for Q4 2023.